BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scheiner B, Kirstein M, Popp S, Hucke F, Bota S, Rohr-Udilova N, Reiberger T, Müller C, Trauner M, Peck-Radosavljevic M, Vogel A, Sieghart W, Pinter M. Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma. Liver Cancer 2019;8:203-17. [PMID: 31192156 DOI: 10.1159/000489833] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Singh Bakshi S. Mean Platelet Volume and Unresectable Hepatocellular Carcinoma. Liver Cancer 2020;9:105-6. [PMID: 32071914 DOI: 10.1159/000502480] [Reference Citation Analysis]
2 Delago D, Knittelfelder O, Jakse G, Lukasiak K, Reinisch S, Renner W, Stranzl-Lawatsch H, Partl R, Langsenlehner T. The decreased mean platelet volume is associated with poor prognosis in patients with oropharyngeal cancer treated with radiotherapy. Radiat Oncol 2020;15:259. [PMID: 33160368 DOI: 10.1186/s13014-020-01702-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Ramadori P, Klag T, Malek NP, Heikenwalder M. Platelets in chronic liver disease, from bench to bedside. JHEP Rep. 2019;1:448-459. [PMID: 32039397 DOI: 10.1016/j.jhepr.2019.10.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
4 Liu PH, Hsu CY, Su CW, Huang YH, Hou MC, Rich NE, Fujiwara N, Hoshida Y, Singal AG, Huo TI. Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma. Liver Int 2020;40:2522-34. [PMID: 32511831 DOI: 10.1111/liv.14560] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Lu L, Zhang Y, Zheng P, Wu Z, Wang X, Chen Y, Chen X. Elevated Platelet Count is Associated with Poor Survival After Transarterial Chemoembolization Treatment in Patients with Hepatocellular Carcinoma: A Cohort Study. J Hepatocell Carcinoma 2020;7:191-9. [PMID: 33117753 DOI: 10.2147/JHC.S274349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Schrecker C, Waidmann O, El Youzouri H, Trojan J, Schnitzbauer AA, Bechstein WO, Zeuzem S, Koch C. Low Platelet Count Predicts Reduced Survival in Potentially Resectable Hepatocellular Carcinoma. Current Oncology 2022;29:1475-87. [DOI: 10.3390/curroncol29030124] [Reference Citation Analysis]
7 Meng Y, Sun J, Zheng Y, Zhang G, Yu T, Piao H. Platelets: The Emerging Clinical Diagnostics and Therapy Selection of Cancer Liquid Biopsies. Onco Targets Ther 2021;14:3417-28. [PMID: 34079287 DOI: 10.2147/OTT.S311907] [Reference Citation Analysis]
8 Lu L, Su Z, Zheng P, Wu Z, Zhang Y, He H, Liu J, Lin S, Chen X. Association between platelet count and hepatocellular carcinoma overall survival: a large retrospective cohort study. BMJ Open 2020;10:e038172. [PMID: 33158820 DOI: 10.1136/bmjopen-2020-038172] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Li M, Liang M, Lan T, Wu X, Xie W, Wang T, Chen Z, Shen S, Peng B. Four Immune-Related Long Non-coding RNAs for Prognosis Prediction in Patients With Hepatocellular Carcinoma. Front Mol Biosci 2020;7:566491. [PMID: 33364253 DOI: 10.3389/fmolb.2020.566491] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Galal G, Tammam H, Abdel Aal A, Fahmy N, Sheneef A, Ahmed N, Zaghloul A. Role of Lymphotoxin-α Gene Polymorphism in Hepatitis C Virus-Related Chronic Liver Disorders. Infect Drug Resist 2021;14:1921-30. [PMID: 34079302 DOI: 10.2147/IDR.S306879] [Reference Citation Analysis]
11 Fan Z, Wu M, Tang Z, He A, Liu F, Liang W, Wang Z, Yang D. Predictive Value of Platelet-Related Measures in Patients with Hepatocellular Carcinoma. Technol Cancer Res Treat 2022;21:15330338211064414. [PMID: 35225081 DOI: 10.1177/15330338211064414] [Reference Citation Analysis]
12 Scheiner B, Kirstein MM, Pinter M. Reply to the Letter to the Editor Entitled "Too Many versus Too Few Platelets in Patients with Hepatocellular Carcinoma: Good or Bad?". Liver Cancer 2020;9:110-1. [PMID: 32071917 DOI: 10.1159/000504301] [Reference Citation Analysis]
13 Mussbacher M, Brunnthaler L, Panhuber A, Starlinger P, Assinger A. Till Death Do Us Part-The Multifaceted Role of Platelets in Liver Diseases. Int J Mol Sci 2021;22:3113. [PMID: 33803718 DOI: 10.3390/ijms22063113] [Reference Citation Analysis]
14 Yuan Y, Zhong H, Ye L, Li Q, Fang S, Gu W, Qian Y. Prognostic value of pretreatment platelet counts in lung cancer: a systematic review and meta-analysis. BMC Pulm Med 2020;20:96. [PMID: 32312252 DOI: 10.1186/s12890-020-1139-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Omran MM, Mosaad S, Emran TM, Eltaweel FM, Farid K. A novel model based on interleukin 6 and insulin-like growth factor II for detection of hepatocellular carcinoma associated with hepatitis C virus. J Genet Eng Biotechnol 2021;19:168. [PMID: 34714420 DOI: 10.1186/s43141-021-00262-8] [Reference Citation Analysis]
16 Chen H, Chen X, Wang G. Platelets: A review of their function and effects in liver diseases. Liver Research 2020;4:129-35. [DOI: 10.1016/j.livres.2020.08.002] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Kharel S, Shrestha S, Shakya P, Rawat R, Shilpakar R. Prognostic significance of mean platelet volume in patients with lung cancer: a meta-analysis. J Int Med Res 2022;50:3000605221084874. [PMID: 35313756 DOI: 10.1177/03000605221084874] [Reference Citation Analysis]
18 Huo TI, Liu PH. Too Many versus Too Few Platelets in Patients with Hepatocellular Carcinoma: Good or Bad? Liver Cancer 2020;9:108-9. [PMID: 32071916 DOI: 10.1159/000503391] [Reference Citation Analysis]
19 Scheiner B, Ulbrich G, Mandorfer M, Reiberger T, Müller C, Waneck F, Trauner M, Kölblinger C, Ferlitsch A, Sieghart W, Peck-Radosavljevic M, Pinter M. Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma. United European Gastroenterol J 2019;7:850-8. [PMID: 31316789 DOI: 10.1177/2050640619840199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
20 Tanaka K, Tsuji K, Matsui T, Kang JH, Sakurai Y, Kodama Y, Minami R, Watanabe K, Katanuma A. Potential of PALBI-T score as a prognostic model for hepatocellular carcinoma in alcoholic liver disease. JGH Open 2022;6:36-43. [PMID: 35071786 DOI: 10.1002/jgh3.12705] [Reference Citation Analysis]
21 Peng W, Li C, Zhang X, Wen T, Chen Z. The impact of thrombocytopenia on prognosis of HBV-related small hepatocellular carcinoma: a propensity score matching analysis. World J Surg Oncol 2021;19:46. [PMID: 33573630 DOI: 10.1186/s12957-021-02160-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Scheiner B, Pinter M. Response to the Letter to the Editor Concerning the Publication "Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma". Liver Cancer 2020;9:107. [PMID: 32071915 DOI: 10.1159/000502745] [Reference Citation Analysis]
23 Pomej K, Balcar L, Scheiner B, Semmler G, Meischl T, Mandorfer M, Reiberger T, Müller C, Trauner M, Pinter M. Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib. J Hepatocell Carcinoma 2021;8:1485-93. [PMID: 34877268 DOI: 10.2147/JHC.S317957] [Reference Citation Analysis]
24 Sanghera C, Teh JJ, Pinato DJ. The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma. Liver Int. 2019;39:2008-2023. [PMID: 31433891 DOI: 10.1111/liv.14220] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]